AJMC July 30, 2023
A white paper crafted by the Association for Accessible Medicines (AAM) outlined that main causes of generic drug shortages and recommended several actions for stakeholders to remedy current shortages and prevent future ones.
The Association for Accessible Medicines (AAM) published a white paper offering stakeholders solutions for ongoing generic and biosimilar drug shortage and supply chain challenges as well as a breakdown of possible causes for shortages.
Generic medicines are the “backbone of the US prescription drug market”, according to AAM, and make up more than 90% of all small molecule prescriptions. The availability of generics has been very stable, even during the COVID-19 pandemic. However, shortages seem to be on the right, affecting roughly 3% of brand-only markets and...
Today's Sponsors
Today's Sponsor